News Search Results
Jun 23, 2026, 19:03 ET Abu Dhabi Opens Strategic Life Sciences Corridor to California Through Biocom Partnership
of the healthcare sector in Abu Dhabi, and Biocom California, one of the world's largest life sciences associations representing more than 1,800 biotechnology, pharmaceutical and medical technology organisations, have announced a strategic partnership that will create a formal gateway between Abu Dhabi
More news about: The Department of Health - Abu Dhabi
Jun 23, 2026, 18:54 ET Abu Dhabi Opens Strategic Life Sciences Corridor to California Through Biocom Partnership
of the healthcare sector in Abu Dhabi, and Biocom California, one of the world's largest life sciences associations representing more than 1,800 biotechnology, pharmaceutical and medical technology organisations, have announced a strategic partnership that will create a formal gateway between Abu Dhabi
More news about: The Department of Health - Abu Dhabi
Jun 23, 2026, 18:45 ET Flagship Pioneering and Lean Business Services Company Announce Collaboration to Advance Healthcare Innovation and AI-Enabled Biomedical Research in Saudi Arabia
Sana Biotechnology,
More news about: Flagship Pioneering
Jun 23, 2026, 14:43 ET New plan to attract foreign investment reinforces market reality on the ground: China Daily editorial
indicates that the world's second-largest economy welcomes multinational companies by creating new opportunities in finance, health care, education, biotechnology and advanced manufacturing. For global businesses, the choice remains straightforward. Markets, efficiency and growth opportunities matter more
More news about: China Daily
Jun 23, 2026, 10:25 ET Ophthalmic Drugs Market Outlook 2026-2031: Over 8% CAGR Projected as Advancements in Ocular Therapeutics Drive Growth, Says Mordor Intelligence
swireOphthalmic Drugs Market Competitive OutlookThe ophthalmic drugs market features global pharmaceutical companies, biotechnology firms, and specialty ophthalmology-focused organizations competing through innovation, product development, and strategic collaborations. Market
More news about: Mordor Intelligence Private Limited
Jun 23, 2026, 10:23 ET Palmer Holland Announces Partnership with FerrinX for Distribution of NanoFerrin™: A Precision-Fermented Bioactive Redefining Modern Skincare
and aligned with the future of biotechnology-enabled skincare."The company expects to begin commercial-scale production later this year, marking an important milestone in bringing precision-fermented lactoferrin to the global skincare industry. As biotechnology continues to reshape ingredient
More news about: Palmer Holland, Inc.
Jun 23, 2026, 10:01 ET Revian Appoints Regenerative Medicine Expert Jordan R. Plews, PhD, as Scientific Advisor
Dr. Plews brings expertise spanning biotechnology, regenerative medicine, and medical aesthetics, reinforcing Revian's foundation of science-led innovation. A stem cell scientist and biochemical
More news about: REVIAN, Inc.
Jun 23, 2026, 09:30 ET Orphan Therapeutics Accelerator Expands its Network to Extend Development and Access Pathways for Ultra-Rare Disease Therapies
OPIS is a global full-service Contract Research Organization (CRO) supporting pharmaceutical, biotechnology, and medical device companies with clinical development, regulatory, and operational services worldwide. Through extensive experience in rare and
More news about: Orphan Therapeutics Accelerator (OTXL)
Jun 23, 2026, 09:17 ET Haisco Enters into Exclusive License Agreement with Nuvectis for Two Drug Candidates in Oncology and Complement Indications
(Ticker Code: 002653) announced that it has entered into an exclusive licensing agreement with Nuvectis, a U.S. biotechnology company. Under the agreement, Haisco has granted Nuvectis the exclusive rights to develop, manufacture, and commercialize its independently developed
More news about: Haisco Pharmaceutical Group Co., Ltd.
Jun 23, 2026, 09:11 ET Wheeler Bio Launches New Website Reflecting Expansion of Capabilities, Clients Served, and a Commitment to High-Science, High-Touch Biologics Manufacturing
communication.The redesigned website features enhanced navigation, expanded technical content, updated service descriptions, and new resources to help biotechnology companies evaluate development and manufacturing strategies available at Wheeler Bio.To explore the new website and learn more about Wheeler
More news about: Wheeler Bio, Inc.
Jun 23, 2026, 09:00 ET NorthLinks Bio Launches with $34 Million Financing to Advance Broad-Spectrum Respiratory Antiviral Platform
–BOSTON, June 23, 2026 /PRNewswire/ -- NorthLinks Bio, a clinical-stage biotechnology company developing broad-spectrum antiviral preventive medicines for respiratory viral infections, today announced both its launch and the completion
More news about: Northlinks Bio
Jun 23, 2026, 08:47 ET Mercury Bio Promotes Casey Perkins to Chief Business Officer
Mercury Bio, an intracellular immunotherapeutic biotechnology company focused on treatments for neurodegenerative diseases such as Alzheimer's and Parkinson's, today announced the promotion of Cassandra "Casey"
More news about: Mercury Bio Inc.
Jun 23, 2026, 08:42 ET Combotope Therapeutics Enters into Collaboration with Boehringer Ingelheim to Advance First-in-Class Tumor-Selective Antibody Therapies for Cancer
COPENHAGEN, Denmark, June 23, 2026 /PRNewswire/ -- Combotope Therapeutics ApS ("Combotope"), a biotechnology company focused on discovering tumor-selective antibodies against cancer-specific glycan-protein targets, today announced a strategic research collaboration
More news about: Combotope Therapeutics ApS
Jun 23, 2026, 08:41 ET Right Brain Bio Selected for Dassault Systèmes' 3DEXPERIENCE Lab; Accelerating Phase 2 Development of Novel Parkinson's Therapy
PLEASANTVILLE, N.Y., June 22, 2026 /PRNewswire/ -- Right Brain Bio, Inc. (RBB), a clinical-stage biotechnology company focused on innovative therapies for Parkinson's disease, today announced its selection into the Dassault Systèmes 3DEXPERIENCE Lab startup
More news about: Right Brain Bio, Inc.
Jun 23, 2026, 08:10 ET Slope and Velocity Clinical Research Partner to Standardize Inventory Management and Drive Study Feasibility Across 70+ Sites
Clinical Research is the world's leading organization of fully-owned and integrated research sites. The company partners with pharmaceutical and biotechnology companies to research new drugs, medical devices, and diagnostics that could improve human health and wellbeing. Velocity's unified research site
More news about: Slope
Jun 23, 2026, 08:04 ET Sparkling Sciences Obtains International INCI Certification for iPSC Exosome
certification recognizes Sparkling Sciences' iPSC Exosome for applications in high-performance skincare, regenerative science research, and advanced biotechnology.iPSC (Induced Pluripotent Stem Cell) is a breakthrough in regenerative medicine. Through cellular reprogramming technology, somatic cells
More news about: Sparkling Sciences Co., Ltd.
Jun 23, 2026, 08:00 ET Rapalogix Health Raises $20 Million in Series A Financing to Redefine the Future of Longevity-Based Skin Health
agingCARLSBAD, Calif., June 23, 2026 /PRNewswire/ -- Rapalogix Health, a biotechnology company pioneering a new category of longevity-based skin health, today announced the successful closing of a $20 million Series A financing round
More news about: Rapalogix Health, Inc.
Jun 23, 2026, 08:00 ET Calico Life Sciences Announces Fosigotifator Granted Breakthrough Therapy Designation by the U.S. FDA for the Treatment of Vanishing White Matter Disease
FRANCISCO, Calif., June 23, 2026 /PRNewswire/ -- Calico Life Sciences LLC (Calico), a clinical-stage biotechnology organization focused on aging and age-related diseases and founded by Alphabet Inc. and Arthur D. Levinson, today announced that the U.S. Food and
More news about: Calico Life Sciences LLC
Jun 23, 2026, 07:03 ET Arzeda Expands Leadership Team with Addition of Alex Patist and Paula Hicks
products and serving as a key interface with partner companies. She has since advised multiple biotechnology startups, including River Stone Biotech. Paula holds a Ph.D. in Chemical Engineering and Biotechnology from North Carolina State University and a Bachelor of Chemical Engineering from the University
More news about: Arzeda
Jun 23, 2026, 07:00 ET Armata Pharmaceuticals Receives $2.5 Million of Additional Non-Dilutive Award Funding from the U.S. Department of Defense to Support AP-SA02
June 23, 2026 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a late clinical-stage biotechnology company focused on the development of high-purity, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat
More news about: Armata Pharmaceuticals, Inc.
Jun 23, 2026, 07:00 ET Mediar Therapeutics Announces First Cohorts Dosed in Phase 1 Clinical Trial of MTX-439 for Fibrosis Associated with Chronic Kidney Disease (CKD) and Additions to Clinical Advisory Board
Mediar Therapeutics, Inc., a clinical-stage biotechnology company pioneering first-in-class therapies to halt and reverse fibrosis, today announced that the first cohorts have been dosed in its Phase 1
More news about: Mediar Therapeutics
Jun 23, 2026, 06:10 ET Ascletis Announces U.S. FDA IND Clearance for Phase I Study of Once-Monthly Subcutaneously Administered GLP-1R/GIPR Dual Peptide Agonist, ASC35, for the Treatment of Obesity
major unmet need in the rapidly growing obesity market."About Ascletis Pharma Inc.Ascletis Pharma Inc. is a fully integrated biotechnology company focused on the development and commercialization of potential best-in-class and first-in-class therapeutics to treat metabolic diseases.
More news about: Ascletis Pharma Inc.
Jun 22, 2026, 17:34 ET Valiant Energy Management Acquires VanDeMark Chemical
("VDM"), a specialty chemical manufacturer with a 75-year history of serving customers across the defense, pharmaceutical, agricultural, industrial, biotechnology, and specialty chemical sectors. The acquisition preserves ongoing operations at VanDeMark's Lockport, New York facility and establishes
More news about: Valiant Energy Management, LLC
Jun 22, 2026, 15:07 ET SystImmune Announces First Approval of Iza-bren for the Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma in China
REDMOND, Wash., June 22, 2026 /PRNewswire/ -- SystImmune Inc. (SystImmune), a clinical-stage biotechnology company, today announced that its parent company, Sichuan Biokin Pharmaceutical Co., Ltd. (Biokin), has received regulatory approval from the Center
More news about: SystImmune, Inc.
Jun 22, 2026, 12:12 ET Postbiotic Supplements Market Demand Reach USD 2.0 Billion by 2036 Amid Rising Demand for Gut Health and Microbiome-Based Wellness Solutions
Manufacturers are investing in advanced fermentation processes to improve ingredient consistency, bioavailability, and functional performance.Biotechnology companies are exploring novel microbial strains and fermentation-derived compounds to create differentiated formulations. Advances in analytical
More news about: Future Market Insights